Skip to content

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

Qi Chen, Michael Graham Espey, Andrew Y. Sun, Chaya Pooput, Kenneth L. Kirk, Murali Cherukuri Krishna, Deena Beneda Khosh, Jeanne Drisko, Mark Levine

Proceedings of the National Academy of Sciences · 2008 · 862 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., & Levine, M. (2008). Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proceedings of the National Academy of Sciences, 105(32), 11105–11109. https://doi.org/10.1073/pnas.0804226105

In text: (Chen et al., 2008)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

Ascorbic acid is an essential nutrient commonly regarded as an antioxidant. In this study, we showed that ascorbate at pharmacologic concentrations was a prooxidant, generating hydrogen-peroxide-dependent cytotoxicity toward a variety of cancer cells in vitro without adversely affecting normal cells. To test this action in vivo, normal oral tight control was bypassed by parenteral ascorbate administration. Real-time microdialysis sampling in mice bearing glioblastoma xenografts showed that a single pharmacologic dose of ascorbate produced sustained ascorbate radical and hydrogen peroxide formation selectively within interstitial fluids of tumors but not in blood. Moreover, a regimen of daily pharmacologic ascorbate treatment significantly decreased growth rates of ovarian (P < 0.005), pancreatic (P < 0.05), and glioblastoma (P < 0.001) tumors established in mice. Similar pharmacologic concentrations were readily achieved in humans given ascorbate intravenously. These data suggest that ascorbate as a prodrug may have benefits in cancers with poor prognosis and limited therapeutic options.

  1. Vitamin C and Immune Function2017
  2. Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention2003
  3. Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications—A Review2014
  4. A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection2020
  5. Plant L‐ascorbic acid: chemistry, function, metabolism, bioavailability and effects of processing2000

Metadata from OpenAlex (CC0). Citations are generated from the published record.